US equities
|
SPCX
$166.88
▲+4.98%
NVDA
$236.84
▲+1.24%
MU
$1,064.09
▼-1.00%
TSLA
$377.15
▲+1.77%
MSFT
$525.02
▲+1.45%
SNDK
$1,708.06
▼-0.69%
INTC
$117.34
▼-1.66%
META
$743.12
▲+2.07%
SPCX
$166.88
▲+4.98%
NVDA
$236.84
▲+1.24%
MU
$1,064.09
▼-1.00%
TSLA
$377.15
▲+1.77%
MSFT
$525.02
▲+1.45%
SNDK
$1,708.06
▼-0.69%
INTC
$117.34
▼-1.66%
META
$743.12
▲+2.07%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Jaguar Health, Inc. - Common Stock
(NQ:
JAGX
)
4.820
+1.160 (+31.69%)
Delayed Quote
Updated: 12:07 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jaguar Health, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China
June 29, 2022
License fees of $5.0 million, and up to $5.0 million in unregistered equity infusion, over next 24 months
From
Jaguar Health, Inc.
Via
AccessWire
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
↗
June 27, 2022
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription...
Via
Benzinga
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi
June 22, 2022
SAN FRANCISCO, CA / ACCESSWIRE / June 22, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that a presentation by Dr. Mohamad Miqdady on short bowel syndrome (SBS) at the Elite Ped-GI Congress,...
From
Jaguar Health, Inc.
Via
AccessWire
45 Stocks Moving In Tuesday's Mid-Day Session
↗
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
67 Biggest Movers From Yesterday
↗
June 22, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Via
Benzinga
Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1
June 21, 2022
Canalevia®-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval...
From
Jaguar Health, Inc.
Via
AccessWire
24 Stocks Moving in Tuesday's Pre-Market Session
↗
June 21, 2022
Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
Via
Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
↗
June 15, 2022
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.
Via
Benzinga
Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
June 13, 2022
Diarrhea is also a prevalent side effect in dogs undergoing cancer treatment; managing diarrhea can be important to maintain successful cancer treatment in both humans and dogs
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
June 10, 2022
All Proposals Approved
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Jaguar Health to Participate in BIO International Convention (BIO 2022)
June 10, 2022
Jaguar seeking partnering meetings at BIO 2022 related to the company's novel plant-based FDA-approved anti-secretory agent for cancer therapy-related diarrhea (CTD) and inflammatory bowel disease...
From
Jaguar Health, Inc.
Via
AccessWire
Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders
↗
June 09, 2022
Filament Health Corp. (OTCQB: FLHLF) and Jaguar Health, Inc. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement.
Via
Benzinga
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
June 09, 2022
Drug Discovery Collaboration Will Leverage the Botanical Drug Development Expertise of Both Companies
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Economy
Jaguar Health's Return On Capital Employed Insights
↗
June 03, 2022
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $2.62 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 26.86%, resulting in a loss of $18.16 million.
Via
Benzinga
Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition
May 25, 2022
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
May 24, 2022
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children resulting in significant morbidity and mortality from severe secretory...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
May 23, 2022
"Canine Cancer: Take C.H.A.R.G.E." (Canine Health And ReGistry Exchange) Based on Nationwide Gallup Poll of Pet Owners and Initial Assessment of More Than 35,000 Canine Medical Records
From
Jaguar Health, Inc.
Via
AccessWire
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
May 19, 2022
Click here to RSVP for this in-person, outdoor event
From
Jaguar Health, Inc.
Via
AccessWire
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
May 17, 2022
Click Here To RSVP for This In-Person, Outdoor Event Human and Doggy Swag Will Be Available*, and the Event Will Feature Presentations by Well-Known Veterinary Cancer Specialists, Including Dr. Sue...
From
Jaguar Health, Inc.
Via
AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
May 16, 2022
Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
30 Stocks Moving in Monday's Pre-Market Session
↗
May 16, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday.
Via
Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
↗
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
May 11, 2022
SAN FRANCISCO, CA / ACCESSWIRE / May 11, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that TAG Investment Bankers Ltd. ("TAG") issued an analyst report today on the company. The paid report...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Announces Launch of Mytesi Telehealth Program
May 11, 2022
This Innovative Program Connects Patients Who May Be Suffering From HIV-Related Diarrhea to a Medical Provider Any Day of the Week and Almost Any Hour of the Day To Determine if Mytesi® Is Medically...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
May 10, 2022
Mytesi® net revenue of $2.6 million increased approximately 24% over the fourth quarter of 2021 and increased approximately 112% over Mytesi net revenue in the first quarter of 2021 Core initiatives: -...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2022
SAN FRANCISCO, CA / ACCESSWIRE / May 6, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective May 6, 2022, the Company granted 50,000 restricted stock...
From
Jaguar Health, Inc.
Via
AccessWire
UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Jaguar Health, Inc.
Via
AccessWire
Earnings Scheduled For May 9, 2022
↗
May 09, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Via
Benzinga
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Jaguar Health, Inc.
Via
AccessWire
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
